Skip to main content

Ultra Low Doses of Rituximab in RA: Dr. Eric Dein and Nathan den Broeder

Nov 08, 2021 4:29 pm

In this interview, panelists discuss abstract #1443 presented at the ACR21 annual meeting.

Add new comment

If you are a health practitioner, you may to comment.

Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.

×